Metal Affinity AAV Capsid Separation Without Toxic Heavy Metals

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for purifying Adeno-associated virus (AAV) capsids, such as affinity chromatography, fail to effectively separate full capsids from empty capsids and contaminating DNA, leading to potential patient safety risks and regulatory compliance issues due to the use of toxic heavy metals and inadequate purification efficiency.

Innovation Solution

A method using immobilized metal affinity chromatography with cationic metal affinity ligands that do not require toxic heavy metals, allowing for the separation of full AAV capsids from empty capsids and reducing DNA contamination through a pH or salt gradient, combined with anion exchange chromatography or density-gradient centrifugation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If traditional affinity chromatography with immobilized metal ions is used to purify AAV capsids, then the purification process is operationally simple, but toxic heavy metals cannot be completely removed and may remain bound to the final product

Engineering Contradiction:
Improveoperational simplicityVSAvoidtoxic metal contamination
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes the toxic heavy metal component from the purification process while retaining the beneficial affinity-based separation mechanism. This is achieved by using alternative non-toxic metal ions or metal-free affinity ligands that can still selectively bind to AAV capsids, thereby eliminating the harmful residue problem while maintaining ease of operation.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces an intermediary substance or mechanism that mediates the binding between AAV capsids and the chromatography matrix without requiring toxic heavy metals. This intermediary could be a bio-based ligand or a non-toxic metal ion that serves as a safe mediator for the affinity interaction, allowing purification to proceed simply without the harmful effects of traditional immobilized metal ions.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If affinity chromatography is used to capture AAV capsids, then the process is simple, but it fails to separate full capsids from empty capsids and contaminating DNA

Engineering Contradiction:
Improveprocess simplicityVSAvoidpurification efficiency
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The invention segments the purification process into multiple specialized steps, each with a specific function: one step for capturing AAV capsids, another for separating full from empty capsids, and a third for removing contaminating DNA. This segmentation allows each step to be optimized for its specific purpose, achieving high purification precision while maintaining overall process simplicity through modular design.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention employs a multi-functional chromatography system where a single integrated approach or sequential combination of methods can simultaneously address multiple purification requirements: capturing capsids, differentiating full from empty capsids, and removing DNA contaminants. This multi-functionality achieves comprehensive purification without requiring complex separate processes.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If nickel ions are used to capture His-tagged AAV, then the capture is effective, but complete nickel removal is difficult and costs for hazardous waste disposal increase

Engineering Contradiction:
Improvecapture effectivenessVSAvoidhazardous waste and disposal costs
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The invention converts the harmful effect of metal ion retention by using non-toxic metal ions or metal-free ligands that do not create hazardous waste problems. The affinity capture mechanism is preserved and remains effective, but the harmful waste disposal issue is eliminated by replacing nickel with safe alternatives, thereby turning a harmful process into a benign one.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The invention may employ disposable or single-use chromatography cartridges or columns that are pre-loaded with affinity ligands. This approach eliminates the need for extensive metal removal and waste disposal procedures, as the entire column can be discarded after use, converting a costly and complex metal removal process into a simpler, more economical single-use system.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves efficient separation of full AAV capsids from empty capsids and significantly reduces DNA contamination, ensuring patient safety and compliance with regulatory standards while avoiding the use of toxic metals.

Implementation Method 1

a metal affinity ligand having the ability to complex metal ions via three or more nitrogen atoms

Methodology Applied
Scientific EffectMetal coordination: Chemical Bonding

Implementation Method 2

Affinity chromatography is popular because it is operationally simple. Most commonly, a biological ligand, such as derived from an antibody, is immobilized on a solid phase chromatography surface

Methodology Applied
Scientific EffectAffinity chromatography: Adsorption

Implementation Method 3

separating empty AAV capsids from full AAV capsids by eluting with a pH gradient, a salt gradient, a metal ion gradient or a combination thereof

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Implementation Method 4

combined with anion exchange chromatography or density-gradient centrifugation

Methodology Applied
Scientific EffectElectrostatic interaction: Electrostatics

Implementation Method 5

combined with anion exchange chromatography or density-gradient centrifugation

Methodology Applied
Scientific EffectDensity gradient centrifugation: Centrifugal Separation

Data Source

PatentUS12533607B2Multimodal metal affinity processing AAV capsids
Publication Date: 2026.01.27 SARTORIUS BIA SEPARATIONS D O O
  • US12533607B2 patent drawing
  • US12533607B2 patent drawing
  • US12533607B2 patent drawing

AI summary

A method for separating full Adeno-associated virus (AAV) capsids from empty AAV capsids in a buffered mixture comprising full AAV capsids, empty AAV capsids, comprising the steps ofcontacting the buffered mixture with a first substrate bearing a metal affinity ligand attached to the first substrate, said metal affinity ligand having the ability to complex metal ions via three or more nitrogen atoms,separating empty AAV capsids from full AAV capsids by eluting with a pH gradient, a salt gradient, a metal ion gradient or a combination thereof in the presence of multivalent cations bound to the metal affinity ligand to obtain a purified full AAV capsid fraction.For removing contaminating DNA in the mixture or purified AAV capsid fraction, the method of the invention can be combined with contacting of the buffered mixture or the purified full AAV capsid fraction with a second substrate bearing a metal affinity ligand attached to the second substrate in the presence of multivalent cations bound to the metal affinity ligand, said metal affinity ligand comprises two or more negatively charged carboxylic acid residues.